CCL11 and vascular disorder: Based on these findings, supplements of chemokines CCL11 may be a new therapeutic strategy for inducing neovascularization and improving perfusion recovery, thereby preventing the occurrence of adverse events such as disability and death in peripheral vascular diseases.